PATENT CLAIM ANALYSIS

Application Number: 15900103
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "275000"]

Abstract:
The invention discloses a use of a statin compound in the preparation of local drugs for improving lipid metabolism and treating obesity, hypertension, hyperlipidemia, fatty liver and hyperglycemia; and statin compound local compositions for improving lipid metabolism and treating obesity, hypertension, fatty liver, hyperlipidemia, atherosclerosis, coronary heart disease, apoplexy and other cardiovascular and cerebrovascular diseases, and drug formulation and preparation method thereof.

Claim (Index 10):
The method of  claim 9 , further comprising adding a degradable materials selected from the group consisting of polylactide, poly-1-lactide-glycolide, a polyaspartic acid.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 88.0
- Lexical Diversity: 1.7619
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14646991', '15254501', '15814557', '15416911', '14941473']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7743698212861284
- 35 USC 102 Novelty (BERT): 0.6291161725107322
- Combined Prediction Score: 0.7598444564085888
- Mean Citation Score: 405.735466
- Max Citation Score: 795.0257
- Similarity Product: 515.4080943205356

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test